AI signal comparison: AbbVie Inc. vs Merck & Co., Inc.
| Metric | ABBV | MRK |
|---|---|---|
| Company | AbbVie Inc. | Merck & Co., Inc. |
| Sector | Healthcare | Healthcare |
| Industry (SIC) | Pharmaceutical Preparations | Pharmaceutical Preparations |
| Insider Activity | elevated | elevated |
| Recent Form 4 Filings | 14 | 15 |
| Recent 8-K Filings | 3 | 0 |
| Filing Frequency | moderate | normal |
| Signals Tracked | 20 | 20 |
| Times Traded | 0 | 0 |
| Total P&L | $0 | $0 |
| Dark Pool Activity | monitoring | monitoring |
| Incorporated | DE | NJ |
Fin45's AI agent monitors both ABBV and MRK across all 11 signal categories. Both operate in the Healthcare sector, meaning they share sector-level signals (rotation, correlation) but have independent company-level signals (insider activity, filings, options flow).
ABBV shows elevated insider activity (14 recent Form 4 filings) compared to MRK's elevated level (15 recent Form 4s). Higher filing frequency in MRK may indicate more active insider positioning.
ABBV has 3 recent 8-K filings (material events) vs MRK's 0. 8-K filings signal corporate events that could affect signal scoring: executive changes, material agreements, acquisitions, or regulatory actions.
Because both ABBV and MRK are in the Healthcare sector, Fin45's 40% sector cap limits combined exposure. The AI agent accounts for correlation between same-sector holdings when sizing positions — holding both simultaneously would require each to be sized smaller.
When both ABBV and MRK show high-conviction signals simultaneously, the agent evaluates: